Actively Recruiting
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
Led by Medstar Health Research Institute · Updated on 2026-02-05
60
Participants Needed
1
Research Sites
114 weeks
Total Duration
On this page
Sponsors
M
Medstar Health Research Institute
Lead Sponsor
C
Congressionally Directed Medical Research Programs
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health. The study aims to understand the perceived benefits, challenges, and opportunities related to Lactobacillus-only, gentamicin-only, and combined gentamicin-Lactobacillus instillations. The main question this study seeks to answer is: 1\. Determine patient and caregivers' preferences, and overall experiences regarding intravesical therapeutics for urinary symptoms and UTI Researchers will compare responses from four groups: participants who have used Lactobacillus-only instillations, gentamicin-only instillations, combined gentamicin-Lactobacillus instillations, and caregivers who have experience supporting instillations. Participants will take part in a one-hour semi-structured interview and may be contacted for brief follow-up discussions to clarify findings. Interviews will be audio-recorded, transcribed, and analyzed using qualitative data software to identify themes related to treatment preferences and acceptability.
CONDITIONS
Official Title
Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Diagnosis of neurogenic lower urinary tract dysfunction (NLUTD)
- Chronic catheter use for at least 6 months, including intermittent or indwelling catheter
- Living in the community (not hospitalized or institutionalized)
- Experience using intravesical Lactobacillus, gentamicin, or their combination
- Caregivers aged 18 or older who care for patients with NLUTD
- Caregivers who support patients using chronic catheters for at least 6 months
- Caregivers experienced in facilitating intravesical Lactobacillus, gentamicin, or combined use
You will not qualify if you...
- Psychiatric or psychological conditions that affect the ability to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medstar National Rehabilitation Hospital
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
Research Team
C
Christopher Riegner, MPH
CONTACT
I
Inger Ljungberg, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here